Michael Feldschuh, President and Chief Executive
Michael has held the position of president and CEO of Daxor Corporation since December 2015. Prior to this, he served as a member of the board of directors before joining Daxor’s executive team in December of 2014. Michael and has over 25 years of experience on Wall Street and in the medical field. He served as a managing director and portfolio manager for Morgan Stanley for six years and a managing director of Millennium Partners for eight years in addition to leading his own hedge fund, Aristarc Capital, from 2009 to 2013. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon. Michael earned his bachelor’s degree in pre-med studies at Columbia College, Columbia University in 1991. Michael’s interests include photography and travel.
Robert J. Michel, Chief Financial Officer
Bob is a certified public accountant and gained his public accounting experience at Price Waterhouse in New York the predecessor firm to pwc. Bob graduated from Villanova University’s School of Business with a degree in Business Administration and has an MBA from St. John’s University. He has a diverse background with more than 30 years of financial experience in manufacturing, advertising and financial services. Immediately prior to joining Daxor Corporation, Bob was the CFO of a moving and storage company most recently at Sher-Del Transfer and Relocation Services. Bob was the CFO for 7 years at Asta Funding, Inc., a publicly traded diversified financial services company that trades on the Nasdaq. He enjoys running, cycling and has hiked across the Grand Canyon.
Jonathan Feldschuh, Chief Scientific Officer
Jonathan is the co-inventor of the BVA-100 and associated patents. He is responsible for algorithmic design, statistical analysis and for patent applications for the next generation blood volume analyzer and its utility across diverse surgical and medical conditions. Jonathan has developed black-box trading and analytical systems for Wall Street firms such as Morgan Stanley, Millennium Partners, and Shearson Lehman and served in the past as chief quantitative officer for Aristarc Capital and as the CEO of Outseeker, a data-driven technology startup. Jonathan has an A.B. in physics summa cum laude from Harvard. He enjoys art and rock climbing.
Soren Thompson, Vice President Business Development
Soren’s responsibilities span public and private sector business development, domestic and international sales management, operations, and corporate strategy. He was an early hire at Hycrete, Inc., where he built an international distribution network across more than 20 countries and five continents. Soren holds a B.A. from Princeton University and an MBA from Columbia University with a focus on Healthcare and Pharmaceutical Management where he has lectured since 2016. He is an NCAA, World and 8-time US National Champion and two-time Olympian in the sport of fencing.
Kathryn A. Kornafel, Vice President Marketing & Commercial Development
Kathy has held leadership roles in global marketing, business development, and sales with major international IVD medical device companies including Abbott, HemoCue and Ortho Clinical Diagnostics. In addition to her business experience, Kathy is an American Society of Clinical Pathology-certified Medical Technologist with clinical lab experience in hematology and microbiology. She holds a bachelor degree in biology from University of Delaware and a bachelor of science degree in medical technology from Thomas Jefferson University. Kathy’s interests include water sports and travel.